[HTML][HTML] Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment

JE Axelrad, S Lichtiger, V Yajnik - World journal of …, 2016 - ncbi.nlm.nih.gov
In patients with inflammatory bowel disease (IBD), chronic inflammation is a major risk factor
for the development of gastrointestinal malignancies. The pathogenesis of colitis-associated …

Cancers complicating inflammatory bowel disease

L Beaugerie, SH Itzkowitz - New England Journal of Medicine, 2015 - Mass Medical Soc
Cancers Complicating Inflammatory Bowel Disease | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …

European evidence-based consensus: inflammatory bowel disease and malignancies

V Annese, L Beaugerie, L Egan… - Journal of Crohn's …, 2015 - academic.oup.com
The global prevalence of cancer is increasing, largely as more patients are living into old
age. Therefore, gastroenterologists caring for patients with inflammatory bowel disease [IBD] …

Progress and problems in understanding and managing primary Epstein-Barr virus infections

OA Odumade, KA Hogquist… - Clinical microbiology …, 2011 - Am Soc Microbiol
Epstein-Barr virus (EBV) is a gammaherpesvirus that infects a large fraction of the human
population. Primary infection is often asymptomatic but results in lifelong infection, which is …

Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990–2017

G Khan, C Fitzmaurice, M Naghavi, LA Ahmed - BMJ open, 2020 - bmjopen.bmj.com
Objective To determine the global and regional burden of Epstein-Barr virus (EBV)-attributed
malignancies. Design An international comparative study based on the Global Burden of …

The rising challenge of non–AIDS-defining cancers in HIV-infected patients

JF Deeken, A Tjen-A-Looi, MA Rudek… - Clinical infectious …, 2012 - academic.oup.com
Since the advent of HAART, patients with HIV infection have seen a significant improvement
in their morbidity, mortality, and life expectancy. The incidence of AIDS-defining illnesses …

Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells

MA Ansari, VV Singh, S Dutta, MV Veettil… - Journal of …, 2013 - Am Soc Microbiol
ABSTRACT Epstein-Barr virus (EBV), etiologically linked with human B-cell malignancies
and nasopharyngeal carcinoma (NPC), establishes three types of latency that facilitate its …

Herpesviruses: harmonious pathogens but relevant cofactors in other diseases?

S Sehrawat, D Kumar, BT Rouse - Frontiers in cellular and infection …, 2018 - frontiersin.org
Most vertebrates are infected with one or more herpesviruses and remain so for the rest of
their lives. The relationship of immunocompetent healthy host with herpesviruses may …

Cancer recurrence following immune-suppressive therapies in patients with immune-mediated diseases: a systematic review and meta-analysis

E Shelton, D Laharie, FI Scott, R Mamtani, JD Lewis… - Gastroenterology, 2016 - Elsevier
Background & Aims Physicians frequently encounter patients with immune-mediated
diseases and a history of malignancy. There are limited data on the safety of …

Nasopharyngeal carcinoma: the next challenges

ARA Razak, LL Siu, FF Liu, E Ito, B O'Sullivan… - European journal of …, 2010 - Elsevier
Nasopharyngeal carcinoma (NPC) differs from other head and neck cancers in its aetiology,
epidemiology and potential therapeutic options. Despite cure for the majority of the patients …